Walleye Capital’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-16,369
| Closed | -$231K | – | 2621 |
|
2024
Q1 | $231K | Buy |
+16,369
| New | +$231K | ﹤0.01% | 1763 |
|
2021
Q4 | – | Sell |
-2,618
| Closed | -$57 | – | 2008 |
|
2021
Q3 | $57 | Sell |
2,618
-20,801
| -89% | -$453 | ﹤0.01% | 1352 |
|
2021
Q2 | $820 | Buy |
+23,419
| New | +$820 | 0.03% | 518 |
|
2020
Q4 | – | Sell |
-8,087
| Closed | -$833K | – | 903 |
|
2020
Q3 | $833K | Buy |
+8,087
| New | +$833K | 0.09% | 269 |
|
2020
Q1 | – | Sell |
-10,932
| Closed | -$1.26M | – | 499 |
|
2019
Q4 | $1.26M | Buy |
10,932
+7,952
| +267% | +$916K | 0.08% | 86 |
|
2019
Q3 | $163K | Buy |
+2,980
| New | +$163K | 0.01% | 228 |
|